These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12142609)

  • 1. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma.
    Chorny JA; Barr RJ
    Am J Dermatopathol; 2002 Aug; 24(4):309-12. PubMed ID: 12142609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma.
    Robson A; Allen P; Hollowood K
    Histopathology; 2001 Feb; 38(2):135-40. PubMed ID: 11207826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation.
    Trejo O; Reed JA; Prieto VG
    J Cutan Pathol; 2002 Aug; 29(7):397-406. PubMed ID: 12139634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX-10 staining in dermal scars.
    Behrens EL; Boothe W; D'Silva N; Walterscheid B; Watkins P; Tarbox M
    J Cutan Pathol; 2019 Aug; 46(8):579-585. PubMed ID: 30950082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
    Kanik AB; Yaar M; Bhawan J
    J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic differentiation of desmoplastic melanoma from cicatrices.
    Kaneishi NK; Cockerell CJ
    Am J Dermatopathol; 1998 Apr; 20(2):128-34. PubMed ID: 9557779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
    Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
    J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
    Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
    Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal Expression of SRY-related HMG-BOX Gene 10 (SOX-10) in Recent and Old Cutaneous Scars is a Potential Mimicker of Desmoplastic Malignant Melanoma.
    Febres-Aldana CA; Alexis J
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):197-204. PubMed ID: 30672775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
    Lazova R; Tantcheva-Poor I; Sigal AC
    J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
    Koch MB; Shih IM; Weiss SW; Folpe AL
    Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
    Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
    Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.
    Otaibi S; Jukic DM; Drogowski L; Bhawan J; Radfar A
    Am J Dermatopathol; 2011 Feb; 33(1):65-71. PubMed ID: 21178583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
    Radfar A; Stefanato CM; Ghosn S; Bhawan J
    Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanotic pigmentation in excision scars of melanocytic and non-melanocytic skin tumors.
    Botella-Estrada R; Sanmartín O; Sevila A; Escudero A; Guillén C
    J Cutan Pathol; 1999 Mar; 26(3):137-44. PubMed ID: 10235379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.
    Anstey A; Cerio R; Ramnarain N; Orchard G; Smith N; Jones EW
    Am J Dermatopathol; 1994 Feb; 16(1):14-22. PubMed ID: 7512798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous desmoplastic melanoma.
    Busam KJ
    Adv Anat Pathol; 2005 Mar; 12(2):92-102. PubMed ID: 15731577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMB-45 recognizes stimulated melanocytes.
    Smoller BR; McNutt NS; Hsu A
    J Cutan Pathol; 1989 Apr; 16(2):49-53. PubMed ID: 2668355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-excisions of scar in primary cutaneous melanoma: a histopathological study.
    Fallowfield ME; Cook MG
    Br J Dermatol; 1992 Jan; 126(1):47-51. PubMed ID: 1536761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.